Myriam Heiman

Broad Institute, Inc.

NIH Rank #823
  • Program Leader
  • Top 5% Funded
  • R01 Holder
  • Translational
  • Multi-Institutional
  • Early Career

NIH Funding · FY2024

Total Funding
$6M
Fiscal year 2024
Grants Awarded
5
Active NIH grants
National Rank
#823
Among 57,894 PIs
First NIH Award
2024
Year of first funding

Funding & rank history

NIH funding totals and national rank by fiscal year.

Single fiscal year on record (FY2024): $6M across 5 grants · National rank #823.

Top grants by award amount

Myriam Heiman's NIH grant portfolio, ranked by award amount.

  • 5U01DA053631-04U01
    Single Cell Transcriptomic and Epigenomic Dissection of Opioid and Cocaine Responses in HIV
    $2.6M
    award amount
  • 5R01NS127187-04R01
    Identification of TDP-43 modifiers through single-cell transcriptional and epigenomic dissection of ALS and FTLD-MND
    $1.8M
    award amount
  • 5R01DA054584-03R01
    Single-Cell Dissection of Ensembles and Cell Types Mediating Opioid Action in the Rodent Brain
    $616.6K
    award amount
  • 5R35NS127327-03R35
    Molecular Mechanisms Underlying Cell Type-Specific Vulnerability in Huntington’s Disease
    $526.6K
    award amount
  • 5R33HL154252-04R33
    Reverse engineering zonation-specific and age-specific iPSC-derived cerebrovascular models based on transcriptomic profiling of the human brain
    $432.2K
    award amount

Career milestones

Key NIH funding milestones over time.

  1. 2024
    First NIH Award
    Broad Institute, Inc.
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    $2M Cumulative Funding
  5. 2024
    $5M Cumulative Funding
  6. 2024
    Entered Top 50% Nationally
    Ranked #823
  7. 2024
    Entered Top 25% Nationally
    Ranked #823
  8. 2024
    Entered Top 10% Nationally
    Ranked #823
  9. 2024
    Entered Top 5% Nationally
    Ranked #823
  10. 2024
    Multi-Institutional Research
    Awards at 4 institutions